PURPOSE: The aim of this study was to use on-tissue reduction followed by MALDI-MS imaging (MSI) to identify an m/z 5812.85 peak, which is over-expressed in healthy human pancreatic tissue compared with type one Diabetes (T1D) tissue. EXPERIMENTAL DESIGN: A major constraint of MALDI-MSI is identification of compounds with m/z ≥4000. On-tissue reduction using tris (2-carboxyethyl) phosphine (TCEP) breaks the inter-domain disulphide bonds generating low-molecular-weight peptides amenable to direct MS/MS analysis. Pancreatic tissues from healthy (n=4) and diabetic subjects (n=4) were profiled by MALDI-MSI with/without reduction. RESULTS: On-tissue reduction resulted in the loss of the over-expressed 5812.85 m/z peak and the simultaneous appearance of a 3430.664 m/z peak in healthy tissues. The latter peak presumably derived from the 5812.85 m/z peak was identified as the insulin B chain by MS/MS. MALDI-MSI images show that both the 5812.85 insulin peak before reduction and the 3430.664 peak after reduction co-localized with the healthy pancreatic islets. CONCLUSION AND CLINICAL RELEVANCE: On-tissue reduction followed by MALDI-MSI resulted in the identification of insulin and localization of pancreatic islets of langerhans. The approach will be useful in the future identification of novel therapeutic molecular targets to β-cells lost during type one diabetes.
PURPOSE: The aim of this study was to use on-tissue reduction followed by MALDI-MS imaging (MSI) to identify an m/z 5812.85 peak, which is over-expressed in healthy humanpancreatic tissue compared with type one Diabetes (T1D) tissue. EXPERIMENTAL DESIGN: A major constraint of MALDI-MSI is identification of compounds with m/z ≥4000. On-tissue reduction using tris (2-carboxyethyl) phosphine (TCEP) breaks the inter-domain disulphide bonds generating low-molecular-weight peptides amenable to direct MS/MS analysis. Pancreatic tissues from healthy (n=4) and diabetic subjects (n=4) were profiled by MALDI-MSI with/without reduction. RESULTS: On-tissue reduction resulted in the loss of the over-expressed 5812.85 m/z peak and the simultaneous appearance of a 3430.664 m/z peak in healthy tissues. The latter peak presumably derived from the 5812.85 m/z peak was identified as the insulin B chain by MS/MS. MALDI-MSI images show that both the 5812.85 insulin peak before reduction and the 3430.664 peak after reduction co-localized with the healthy pancreatic islets. CONCLUSION AND CLINICAL RELEVANCE: On-tissue reduction followed by MALDI-MSI resulted in the identification of insulin and localization of pancreatic islets of langerhans. The approach will be useful in the future identification of novel therapeutic molecular targets to β-cells lost during type one diabetes.
Authors: Michael Mormann; Johannes Eble; Christian Schwöppe; Rolf M Mesters; Wolfgang E Berdel; Jasna Peter-Katalinić; Gottfried Pohlentz Journal: Anal Bioanal Chem Date: 2008-07-29 Impact factor: 4.142
Authors: Jutta E Laiho; Maarit Oikarinen; Sarah J Richardson; Gun Frisk; Julius Nyalwidhe; Tanya C Burch; Margaret A Morris; Sami Oikarinen; Alberto Pugliese; Francesco Dotta; Martha Campbell-Thompson; Jerry Nadler; Noel G Morgan; Heikki Hyöty Journal: J Clin Virol Date: 2016-02-02 Impact factor: 3.168
Authors: Boone M Prentice; Nathaniel J Hart; Neil Phillips; Rachana Haliyur; Audra Judd; Radhika Armandala; Jeffrey M Spraggins; Cindy L Lowe; Kelli L Boyd; Roland W Stein; Christopher V Wright; Jeremy L Norris; Alvin C Powers; Marcela Brissova; Richard M Caprioli Journal: Diabetologia Date: 2019-04-06 Impact factor: 10.122
Authors: Alberto Pugliese; Francesco Vendrame; Helena Reijonen; Mark A Atkinson; Martha Campbell-Thompson; George W Burke Journal: Curr Diab Rep Date: 2014-10 Impact factor: 4.810
Authors: Tanya C Burch; Margaret A Morris; Martha Campbell-Thompson; Alberto Pugliese; Jerry L Nadler; Julius O Nyalwidhe Journal: PLoS One Date: 2015-08-24 Impact factor: 3.240
Authors: Alberto Pugliese; Mingder Yang; Irina Kusmarteva; Tiffany Heiple; Francesco Vendrame; Clive Wasserfall; Patrick Rowe; Jayne M Moraski; Suzanne Ball; Les Jebson; Desmond A Schatz; Roberto Gianani; George W Burke; Concepcion Nierras; Teo Staeva; John S Kaddis; Martha Campbell-Thompson; Mark A Atkinson Journal: Pediatr Diabetes Date: 2013-12-10 Impact factor: 4.866